Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.19083 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.16919 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.18017 | 8 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.11545 | 7 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.11677 | 7 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.2216 | 8 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.18253 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.14521 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.14067 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.15842 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.15363 | 7 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.13853 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.27239 | 11 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.15964 | 7 |